The unified social credit code/registration number of Liaocheng Kangrui Renhe Pharmaceutical Co., Ltd. is 9137150016821186q, and the enterprise is in the state of opening.
The business scope of Liaocheng Kangrui Renhe Medicine Co., Ltd. is: Chinese herbal pieces, proprietary Chinese medicines, chemical raw materials, chemical preparations, antibiotics, biochemical drugs, biological products (except vaccines), implant materials and artificial organs, interventional instruments, in vitro diagnostic reagents, injection puncture instruments, medical polymer materials and products, medical electronic instruments and equipment, medical optical instruments, instruments and endoscopic equipment (except corneal contact lenses and nursing solutions), and medical ultrasonic instruments. Medical laser instruments and equipment, medical high-frequency instruments and equipment, physical therapy rehabilitation equipment, medical magnetic vibration equipment, medical X-ray equipment, clinical examination and analysis equipment, extracorporeal circulation and blood treatment equipment, operating room and emergency room equipment and appliances, dental materials, medical hygiene materials and dressings, medical suture materials and adhesives (operated with valid Drug Business License and Medical Device Business License). Category I and Category II medical devices (except licensing), health food, wholesale and retail in disinfection products. (The above-mentioned business projects must be approved according to law, and business activities can only be carried out after being approved by relevant departments). In Shandong province, the total registered capital of companies with similar business scope is 572.25 million yuan, and the main capital is concentrated in 22 enterprises with scale of 50 million or above,1000-50 million. Within the scope of this province, the registered capital of mobile enterprises belongs to the general.
View more information and materials of Liaocheng Kangrui Renhe Pharmaceutical Co., Ltd. through Baidu Enterprise Credit.